Actinium Pharmaceuticals (ATNM) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ATNM is expected to report earnings to rise 25.16% to -38 cents per share on August 26

Actinium Pharmaceuticals ATNM Stock Earnings Reports

Q2'24

Est.

$-0.39

Q1'24

Beat

by $0.06

Q4'23

Beat

by $0.23

Q3'23

Est.

$-0.49

Q2'23

Missed

by $0.02

The last earnings report on May 13 showed earnings per share of -31 cents, beating the estimate of -36 cents. With 245.87K shares outstanding, the current market capitalization sits at 56.08M.

View a ticker or compare two or three

Compare

ATNM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ATNM
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

100 Park Avenue

Phone

+1 646 677-3870

Employees

Web

https://www.actiniumpharma.com